ACTB has a poor prognosis with high expression in 14 tumor types (GBMLGG, LGG, MESO, KIPAN, KIRC, UVM, KICH, LAML, HNSC, LIHC, LUAD, GBM, PAAD, ACC) and a poor prognosis with low expression in 1 tumor type (OV) (Figure 6A). Here, ACTB is linked to neoplasm.